AMG-333
Drug which acts as a potent and selective blocker of the TRPM8 ion channel
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C20H12F5N3O4 |
Molar mass | 453.325 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
AMG-333 is a drug which acts as a potent and selective blocker of the TRPM8 ion channel, which is the main receptor responsible for the sensation of cold. It was developed as a potential treatment for migraine.[1]
See also
- PF-05105679
- RQ-00203078
References
- ^ Horne DB, Biswas K, Brown J, Bartberger MD, Clarine J, Davis CD, et al. (September 2018). "Discovery of TRPM8 Antagonist ( S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine". Journal of Medicinal Chemistry. 61 (18): 8186–8201. doi:10.1021/acs.jmedchem.8b00518. PMID 30148953. S2CID 52095823.
- v
- t
- e
TRP channel modulators
Activators | |
---|---|
Blockers |
|
Activators |
|
---|---|
Blockers |
|
Activators | |
---|---|
Blockers |
|
Activators | |
---|---|
Blockers |
See also: Receptor/signaling modulators • Ion channel modulators
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e